Rafael Holdings/$RFL
14:30
15:25
16:15
17:10
18:00
1D1W1MYTD1Y5YMAX
About Rafael Holdings
Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.
Ticker
$RFL
Sector
Primary listing
NYSE
Employees
22
Headquarters
Website
Rafael Holdings Metrics
BasicAdvanced
$61M
-
-$1.04
0.68
-
Price and volume
Market cap
$61M
Beta
0.68
52-week high
$3.19
52-week low
$1.17
Average daily volume
83K
Financial strength
Current ratio
4.889
Quick ratio
4.707
Long term debt to equity
0.079
Total debt to equity
0.703
Interest coverage (TTM)
-38.16%
Profitability
EBITDA (TTM)
-24.821
Gross margin (TTM)
85.39%
Net profit margin (TTM)
-3,328.24%
Operating margin (TTM)
-2,738.17%
Effective tax rate (TTM)
7.69%
Revenue per employee (TTM)
$40,000
Management effectiveness
Return on assets (TTM)
-14.88%
Return on equity (TTM)
-33.19%
Valuation
Price to revenue (TTM)
37.862
Price to book
0.64
Price to tangible book (TTM)
0.83
Price to free cash flow (TTM)
-1.833
Free cash flow yield (TTM)
-54.56%
Free cash flow per share (TTM)
-0.644
Growth
Revenue change (TTM)
43.96%
Earnings per share change (TTM)
-28.28%
3-year revenue growth (CAGR)
30.78%
10-year revenue growth (CAGR)
-13.67%
3-year earnings per share growth (CAGR)
-45.16%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Rafael Holdings stock?
Rafael Holdings (RFL) has a market cap of $61M as of December 01, 2025.
What is the P/E ratio for Rafael Holdings stock?
The price to earnings (P/E) ratio for Rafael Holdings (RFL) stock is 0 as of December 01, 2025.
Does Rafael Holdings stock pay dividends?
No, Rafael Holdings (RFL) stock does not pay dividends to its shareholders as of December 01, 2025.
When is the next Rafael Holdings dividend payment date?
Rafael Holdings (RFL) stock does not pay dividends to its shareholders.
What is the beta indicator for Rafael Holdings?
Rafael Holdings (RFL) has a beta rating of 0.68. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.